Literature DB >> 12189144

JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery.

Nicole Donovan1, Esther B E Becker, Yoshiyuki Konishi, Azad Bonni.   

Abstract

The c-Jun N-terminal kinase (JNK) signaling pathway plays a critical role in mediating apoptosis in the developing and mature organism. The JNK signaling pathway is thought to induce apoptosis via transcription-dependent and transcription-independent mechanisms that remain to be elucidated. In this study, we report a novel mechanism by which the JNK signaling pathway directly activates a component of the cell death machinery. We have found that JNK catalyzes the phosphorylation of the BH3-only protein BAD at the distinct site of serine 128 in vitro. Activation of the JNK signaling pathway induces the BAD serine 128 phosphorylation in vivo, including in primary granule neurons of the developing rat cerebellum. The JNK-induced BAD serine 128 phosphorylation promotes the apoptotic effect of BAD in primary neurons by antagonizing the ability of growth factors to inhibit BAD-mediated apoptosis. These findings indicate that BAD is a novel substrate of JNK that links the stress-activated signaling pathway to the cell death machinery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189144     DOI: 10.1074/jbc.M206113200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

1.  Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway.

Authors:  Ning Gao; Senping Cheng; Amit Budhraja; Ziyi Gao; Jieping Chen; E-Hu Liu; Cheng Huang; Deying Chen; Zailin Yang; Qun Liu; Ping Li; Xianglin Shi; Zhuo Zhang
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

Review 3.  Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.

Authors:  Juan Wang; Guixiang Tai
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

4.  Mutually exclusive subsets of BH3-only proteins are activated by the p53 and c-Jun N-terminal kinase/c-Jun signaling pathways during cortical neuron apoptosis induced by arsenite.

Authors:  Hon Kit Wong; Michael Fricker; Andreas Wyttenbach; Andreas Villunger; Ewa M Michalak; Andreas Strasser; Aviva M Tolkovsky
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

Review 5.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

Review 6.  JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities.

Authors:  Sidharth Mehan; Harikesh Meena; Deepak Sharma; Rameshwar Sankhla
Journal:  J Mol Neurosci       Date:  2010-09-28       Impact factor: 3.444

Review 7.  Programmed cell death and new discoveries in the genetics of parkinsonism.

Authors:  Robert E Burke
Journal:  J Neurochem       Date:  2007-12-10       Impact factor: 5.372

8.  Sunlight UV-induced skin cancer relies upon activation of the p38α signaling pathway.

Authors:  Kangdong Liu; Donghoon Yu; Yong-Yeon Cho; Ann M Bode; Weiya Ma; Ke Yao; Shengqing Li; Jixia Li; G Tim Bowden; Ziming Dong; Zigang Dong
Journal:  Cancer Res       Date:  2013-02-04       Impact factor: 12.701

9.  JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins.

Authors:  Fuminori Tsuruta; Jun Sunayama; Yasunori Mori; Seisuke Hattori; Shigeomi Shimizu; Yoshihide Tsujimoto; Katsuji Yoshioka; Norihisa Masuyama; Yukiko Gotoh
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

Review 10.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.